Difficulty: Medium
Average Score: 85%
Practice
Methylxanthines for the treatment of broncho-pulmonary dysplasia (BPD) have the following effects EXCEPT
Correct answer
D
Rationale
In the treatment of broncho-pulmonary dysplasia (BPD), methylxanthines such as caffeine are commonly used due to their respiratory stimulant effects. The correct answer, option D, states that methylxanthines do not increase pulmonary vascular resistance (PVR). This is accurate because methylxanthines actually have a vasodilatory effect on the pulmonary vasculature, reducing PVR.
Option A, increasing respiratory drive, is a known effect of methylxanthines. They stimulate the central nervous system, leading to an increase in respiratory rate and depth. Option B, decreasing apnea, is also a well-documented effect of methylxanthines as they help in reducing the incidence of apnea of prematurity in infants.
Option C, improving diaphragmatic contractility, is not directly related to the effects of methylxanthines. While these medications primarily work by stimulating the respiratory centers in the brain, they do not have a direct effect on diaphragmatic contractility.
In an educational context, understanding the effects of medications used in the treatment of respiratory conditions such as BPD is crucial for pediatric nurses. It allows for safe and effective administration of these drugs, as well as monitoring for both therapeutic effects and potential adverse reactions. This knowledge helps nurses provide comprehensive care to pediatric patients with respiratory issues and ensures optimal outcomes for these vulnerable populations.
Option A, increasing respiratory drive, is a known effect of methylxanthines. They stimulate the central nervous system, leading to an increase in respiratory rate and depth. Option B, decreasing apnea, is also a well-documented effect of methylxanthines as they help in reducing the incidence of apnea of prematurity in infants.
Option C, improving diaphragmatic contractility, is not directly related to the effects of methylxanthines. While these medications primarily work by stimulating the respiratory centers in the brain, they do not have a direct effect on diaphragmatic contractility.
In an educational context, understanding the effects of medications used in the treatment of respiratory conditions such as BPD is crucial for pediatric nurses. It allows for safe and effective administration of these drugs, as well as monitoring for both therapeutic effects and potential adverse reactions. This knowledge helps nurses provide comprehensive care to pediatric patients with respiratory issues and ensures optimal outcomes for these vulnerable populations.